WILMINGTON, DE – A federal jury ordered Medtronics, Inc. to pay $73.5 million to Edwards Lifesciences Corp. after finding that Medtronics violated the patent on Edwards’ Sapien XT heart valve. The jury determined that Medtronic’s CoreValve line willfully infringed on Edwards’ patent that relates to artificial valves implanted via catheter.

Partners John Nathan and Catherine Nyarady (Paul Weiss) represented Edwards Lifesciences at trial, with Impact Trial’s Jesse W. Stevenson, Joel DePalma and Kara Lyon working closely with the litigation team to provide invaluable litigation graphics and trial technology consulting and support throughout the trial.

Edwards Lifesciences, et al., v. Medtronic CoreValve, LLC, et al., 1: 12-CV-00023, US District Court – Delaware.